Catch the wave: How AI can power drug discovery
Mike Wolfe recalls that when he first heard Research Rising announced in 2021, he had yet to formulate ideas about using “big data”—a combination of artificial intelligence technology and its related computational field, machine learning—to develop drug molecules. His expertise is in medicinal chemistry, not advanced computing, but as he began to learn about big data’s applications being used in private industry, a plan soon came together.
Read the complete article by Chris Lazzarino from "Kansas Alumni" magazine.
